Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia.
McClay JL, Adkins DE, Aberg K, Bukszár J, Khachane AN, Keefe RS, Perkins DO, McEvoy JP, Stroup TS, Vann RE, Beardsley PM, Lieberman JA, Sullivan PF, van den Oord EJ.
McClay JL, et al. Among authors: beardsley pm.
Neuropsychopharmacology. 2011 Feb;36(3):616-26. doi: 10.1038/npp.2010.193. Epub 2010 Nov 24.
Neuropsychopharmacology. 2011.
PMID: 21107309
Free PMC article.